- Home
- RMBI vs MYO Comparison
RMBI vs MYO Comparison
Compare RMBI & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMBI
- MYO
- Stock Information
- Founded
- RMBI 1887
- MYO 2004
- Country
- RMBI United States
- MYO United States
- Employees
- RMBI N/A
- MYO N/A
- Industry
- RMBI Major Banks
- MYO Industrial Specialties
- Sector
- RMBI Finance
- MYO Health Care
- Exchange
- RMBI Nasdaq
- MYO Nasdaq
- Market Cap
- RMBI 127.9M
- MYO 113.3M
- IPO Year
- RMBI 2019
- MYO 2017
- Fundamental
- Price
- RMBI $13.61
- MYO $4.67
- Analyst Decision
- RMBI
- MYO Strong Buy
- Analyst Count
- RMBI 0
- MYO 4
- Target Price
- RMBI N/A
- MYO $7.75
- AVG Volume (30 Days)
- RMBI 14.2K
- MYO 185.7K
- Earning Date
- RMBI 10-24-2024
- MYO 11-06-2024
- Dividend Yield
- RMBI 4.12%
- MYO N/A
- EPS Growth
- RMBI N/A
- MYO N/A
- EPS
- RMBI 0.87
- MYO N/A
- Revenue
- RMBI $42,258,196.00
- MYO $25,239,125.00
- Revenue This Year
- RMBI N/A
- MYO $53.19
- Revenue Next Year
- RMBI N/A
- MYO $39.01
- P/E Ratio
- RMBI $15.66
- MYO N/A
- Revenue Growth
- RMBI N/A
- MYO 36.23
- 52 Week Low
- RMBI $10.11
- MYO $2.51
- 52 Week High
- RMBI $13.64
- MYO $5.64
- Technical
- Relative Strength Index (RSI)
- RMBI 70.77
- MYO 60.20
- Support Level
- RMBI $13.20
- MYO $4.50
- Resistance Level
- RMBI $13.21
- MYO $5.05
- Average True Range (ATR)
- RMBI 0.25
- MYO 0.34
- MACD
- RMBI 0.06
- MYO 0.08
- Stochastic Oscillator
- RMBI 97.14
- MYO 61.36
About RMBI Richmond Mutual Bancorporation Inc.
Richmond Mutual Bancorp Inc is a United States-based banking company. Its principal business consists of attracting deposits from the general public & brokered deposits and investing those funds predominantly in loans secured by commercial and multi-family real estate, first mortgages on owner-occupied, one-to four-family residences, a variety of consumer loans, direct financing leases, and commercial and industrial loans.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The Company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The Company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).